Overview

Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.
Phase:
Phase 2
Details
Lead Sponsor:
XOMA (US) LLC